… All patients treated within the six clinical trials who received at least one coronary stent and
who were treated with aspirin and ticlopidine following the stent procedure were eligible for …

… the treatment of patients with coronary artery disease, stent restenosis … patients undergoing
coronary stenting will require coronary intervention anew within 12 months because of stent …

… stent was shown in small registry studies and randomized clinical trials to reduce the risk of
restenosis in patients who … -eluting stent in patients with more challenging coronary stenoses. …

… At 73 US centers, we enrolled 1314 patients who were receiving a stent in a single, previously
untreated coronary… A total of 652 patients were randomly assigned to receive a bare-metal …

… In a randomized, double-blind trial, we compared the drug-coated stent with a very similar
bare-metal stent in patients with a high risk of bleeding who underwent PCI. All patients …

… in diabetic patients treated with coronary stents is due to enhanced late loss of luminal
diameter, which may be caused by more pronounced smooth muscle hyperplasia within the stent. …

… coronary stent may be extremely useful in selecting patients at higher risk of coronary events
after successful stent … be confirmed in larger trials, patients with low postprocedural plasma …

… Paclitaxel-eluting stent versus sirolimus-eluting stent for the prevention of restenosis in
diabetic patients with coronary artery disease (ISAR-DIABETES). Paper presented at: 2005 …

… In our patients, no residual stenosis was quantified inside the stent, and a progressive stent
diameter improvement was observed at 15 minutes in the case of self-expandable Wallstent …

… and de novo coronary disease, and 26% of patients had a history of diabetes, the current
study population had much higher proportions of UA (44.6%), previous coronary disease (49.7…